Drug Formulary Review Archives – February 1, 2007
February 1, 2007
View Issues
-
Hospital productivity monitoring misses clinical workload data
A survey of U.S. community hospitals that were part of a national group purchasing organization charged with identifying and characterizing pharmacy productivity monitoring systems found the systems often failed to capture all relevant clinical workload data. -
The role of pharmacists' continues to change
The practice of pharmacy has changed significantly in recent years, and continues to evolve today, according to MLC Solutions principals Charlotte Kenreigh, PharmD, and Linda Timm Wagner, PharmD. -
More pharmacist involvement needed in ED
Increased development of emergency department (ED) pharmacy services and increasing involvement of pharmacists in hospital EDs can contribute to improvements in ED shortcomings identified in a recent Institute of Medicine report on the future of emergency care in the U.S. health system. -
News Briefs
Telephone management of anticoagulation treatment works; FDA wants to change rules to expand experimental drug availability; Aprotinin injection labeling revised; FDA warns of safety concern with rituximab; FDA approves novel device for brain damage in infants; Pfizer ends phase 3 torcetrapib/atorvastatin trial -
Oxymorphone (Opana®) Formulary Evaluation
Matsumoto AK, Babul N, Ahdieh H. Oxymorphone ER tablets relieve moderate to severe pain and improve physical function is osteoarthritis: Results of a randomized, double-blind, placebo and active-controlled Phase III Trial. J Pain 2005; 6:357-366. -
A FREE white paper for you!
AHC Media appreciates the faith you have placed in us to provide you with practical, authoritative information. As a token of our gratitude for your support, we would like to provide you with the free white paper, The Joint Commission: What Hospitals Can Expect in 2007.